Lupin Launches Formoflo-G® MDI, World's First Triple Combination Drug For COPD In India
Mumbai: Lupin Limited on 6 October 2026 announced the launch of Formoflo-G® MDI, a fixed-dose triple combination metered-dose inhaler for the management of chronic obstructive pulmonary disease (COPD) in India. Regulatory Approval The launch follows approval from the Drug Controller General of India (DCGI), marking an expansion of treatment options for patients with COPD. Product Details Lupin…
We haven't written up this one. Free Press Journal has the full story — the link below goes straight to it.
